ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,803Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 1300

$1.59M Total Retail Price of All Prescriptions

Rank: 1 out of 1300

767 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 767 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

20% of this provider’s 767 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 30,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
WARFARIN SODIUM 2,430 2,305 1 9
LEVOTHYROXINE SODIUM 1,855 1,741 2 1
FUROSEMIDE 1,378 1,314 3 8
HYDROCODONE-ACETAMINOPHEN 1,052 952 S3 4 5
LISINOPRIL 995 934 5 2
METOPROLOL TARTRATE 869 850 6 11
OMEPRAZOLE 767 709 7 4
CITALOPRAM HBR 715 665 8 19
POTASSIUM CHLORIDE 667 655 9 18
SIMVASTATIN 605 522 10 3
LIDODERM 539 533 11 74
GABAPENTIN 502 394 12 15
DONEPEZIL HCL 464 446 13 32
QUETIAPINE FUMARATE 424 368 14 57
MIRTAZAPINE 411 409 15 50
DIVALPROEX SODIUM 410 357 16 62
OXYCODONE-ACETAMINOPHEN 397 339 S2 17 28
AMLODIPINE BESYLATE 394 386 18 6
OXYCODONE HCL 370 341 S2 19 35
LANTUS 365 301 20 43
TAMSULOSIN HCL 359 321 21 25
ATENOLOL 358 357 22 12
LACTULOSE 341 308 23 132
ESCITALOPRAM OXALATE 306 284 24 84
OXYCONTIN 298 276 S2 25 70
METFORMIN HCL 291 233 26 7
RAMIPRIL 277 270 27 137
PAROXETINE HCL 265 243 28 59
CYMBALTA 264 231 29 44
TRAMADOL HCL 257 240 30 17
IPRATROPIUM-ALBUTEROL 256 223 31 127
RANITIDINE HCL 252 252 32 27
KLOR-CON M20 246 222 33 60
FENTANYL 246 229 S2 33 56
FAMOTIDINE 245 218 35 73
GLIPIZIDE 235 229 36 33
METOPROLOL SUCCINATE 234 230 37 24
PREDNISONE 232 212 38 40
SERTRALINE HCL 222 203 39 26
CARBIDOPA-LEVODOPA 216 199 40 68
LEVOFLOXACIN 215 200 41 103
KLOR-CON 10 205 205 42 130
NAMENDA 200 200 43 51
NYSTATIN 197 191 44 135
POLYETHYLENE GLYCOL 3350 196 165 45 65
SEROQUEL 195 165 46 146
ALENDRONATE SODIUM 191 187 47 20
ALLOPURINOL 190 189 48 29
RISPERIDONE 177 106 49 77
SPIRIVA 174 128 50 45
DIGOXIN 165 165 51 48
PANTOPRAZOLE SODIUM 165 154 51 36
ATORVASTATIN CALCIUM 164 148 53 13
CIPROFLOXACIN HCL 162 153 54 87
LYRICA 160 145 55 75
CARVEDILOL 156 140 56 38
CLOPIDOGREL 155 144 57 64
TRAZODONE HCL 151 147 58 34
LEVETIRACETAM 149 114 59 107
OLANZAPINE 147 130 60 86
DIOVAN 138 138 61 66
VENLAFAXINE HCL 131 106 62 152
SPIRONOLACTONE 131 112 62 55
DIVALPROEX SODIUM ER 127 90 64 165
FLUOXETINE HCL 126 114 65 31
HYDROCHLOROTHIAZIDE 124 122 66 10
PLAVIX 123 114 67 112
ADVAIR DISKUS 123 112 67 41
MORPHINE SULFATE ER 121 86 S2 69 49
LOSARTAN POTASSIUM 116 115 70 16
MORPHINE SULFATE 115 107 S2 71 157
ABILIFY 113 78 72 129
VENLAFAXINE HCL ER 107 94 73 69
IPRATROPIUM BROMIDE 106 100 74 237
METOCLOPRAMIDE HCL 99 83 75 143
ROPINIROLE HCL 95 92 76 106
FINASTERIDE 93 82 77 80
DILTIAZEM 24HR CD 91 79 78 139
BACLOFEN 89 59 79 100
AZITHROMYCIN 89 85 79 79
LOVASTATIN 87 83 81 22
HYDROMORPHONE HCL 85 69 S2 82 141
FLUTICASONE PROPIONATE 85 59 82 30
OXYBUTYNIN CHLORIDE ER 84 51 84 101
NOVOLOG 80 79 85 156
ENOXAPARIN SODIUM 80 73 85 203
ISOSORBIDE MONONITRATE ER 76 73 87 82
CEPHALEXIN 75 72 88 89
PROPRANOLOL HCL 72 72 89 116
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 71 89 128
AMIODARONE HCL 71 71 91 249
OXYBUTYNIN CHLORIDE 70 55 92 97
NOVOLIN R 69 44 93 211
LEXAPRO 67 65 94 190
NYSTOP 67 60 94 188
HALOPERIDOL 66 29 96 224
LIDOCAINE HCL 66 64 96 302
HYDROXYZINE HCL 65 59 R 98 230
MELOXICAM 64 62 99 47
CARBAMAZEPINE 64 31 99 125
TIMOLOL MALEATE 63 63 101 306
DILTIAZEM ER 63 63 101 154
LAMOTRIGINE 63 31 101 119
CEFTRIAXONE 63 62 101 260
CLONIDINE HCL 62 46 105 102
LITHIUM CARBONATE 61 47 106 168
DOXAZOSIN MESYLATE 60 60 107 71
ALBUTEROL SULFATE 57 50 108 162
NITROGLYCERIN PATCH 57 57 108 197
AMOXICILLIN 57 54 108 177
HYDRALAZINE HCL 55 43 111 133
PRAVASTATIN SODIUM 53 53 112 23
BYSTOLIC 53 53 112 117
SANTYL 52 45 114 339
GLIPIZIDE XL 52 52 114 142
NOVOLIN N 51 51 116 88
RESTASIS 50 20 117 355
NAPROXEN 50 44 117 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.